Bio-Techne (TECH) And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Bio-Techne (TECH) Declares $0.32 Quarterly Dividend; 0.5% Yield
August 4, 2020 6:44 AM EDTBio-Techne (NASDAQ: TECH) declared a quarterly dividend of $0.32 per share, or $1.28 annualized.
The dividend will be payable on August 28, 2020, to stockholders of record on August 18, 2020, with an ex-dividend date of August 17, 2020.
The annual yield on the dividend is 0.5 percent.
For a... More
Bio-Techne (TECH) Adds Julie L. Bushman to Board
August 3, 2020 7:09 AM EDTBio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020. Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of... More
